Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial.
about
Lipid posttranslational modifications. Farnesyl transferase inhibitors.A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemiaPhase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205.Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.Tipifarnib in the treatment of acute myeloid leukemia.
P2860
Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Intermittent dosing of the far ...... ornia Cancer Consortium Trial.
@ast
Intermittent dosing of the far ...... ornia Cancer Consortium Trial.
@en
type
label
Intermittent dosing of the far ...... ornia Cancer Consortium Trial.
@ast
Intermittent dosing of the far ...... ornia Cancer Consortium Trial.
@en
prefLabel
Intermittent dosing of the far ...... ornia Cancer Consortium Trial.
@ast
Intermittent dosing of the far ...... ornia Cancer Consortium Trial.
@en
P2093
P1433
P1476
Intermittent dosing of the far ...... ornia Cancer Consortium Trial.
@en
P2093
Derick H M Lau
James H Doroshow
John J Wright
Lisa Y Law
Paul Frankel
Paul H Gumerlock
Primo N Lara
Przemyslaw Twardowski
Tomoya Kawaguchi
P304
P356
10.1097/00001813-200503000-00011
P577
2005-03-01T00:00:00Z